STARTING IBSRELA
Let’s do this...
Don't miss the latest information, tips, and resources.
Sign up nowKEEP AN EYE OUT FOR THESE 3 THINGS
E xpect a welcome call from your pharmacy.
Within 24 hours for prescriptions sent to the IBSRELA Pharmacy Network.
Y our pharmacy will reach out to confirm your delivery preferences. It’s important that you pick up the phone or answer the text.
E xplore savings with the IBSRELA Copay Program.
$0* Pay as little as $0 for IBSRELA
Patients with commercial insurance pay as little as $0 per 30-day or 90-day prescription fill of IBSRELA.
The discount will be automatically applied for eligible patients.
*Please see terms and conditions.
We're here to help.
If you have questions or need support with IBSRELA access or affordability, please reach out to 1-844-427-7352, Option 1.
How to take IBSRELA
IBSRELA is a 50mg tablet that is taken twice a day, just before breakfast and just before dinner.
Things to keep in mind when taking IBSRELA:
- If you miss a dose, skip the missed dose, and take the next dose at the regular time
- Do not take 2 doses of IBSRELA at the same time
- Talk to your healthcare provider if you have questions about taking IBSRELA
Welcome to IBSRELA
Starting IBSRELA? Here’s what you need to know
THE IBS-CONNECTION
The Importance of Shared Decision-Making
Susan, a nurse practitioner, works closely with her patients to keep them informed about different medications, because she knows there is no one-size-fits-all approach to treating IBS‑C.†
†Susan is a compensated advisor to Ardelyx.
View transcript
ON SCREEN/SUPER: Susan Wolgamott, DNP
Susan is a compensated advisor to Ardelyx
Susan VO:
Because there are many potential underlying causes of IBS‑C, there is no one-size-fits-all treatment approach.
That’s why I let my patients know that we have different medications to treat IBS‑C, which is good because there are many underlying causes for this condition, and classes of drugs work differently for different people.
I also talk to my patients about the importance of having good two-way communication between us. There will be a lot of trial and error to find the right medication for each patient, but with a collaborative, joint decision-making process, we will work together to find the treatment that is right for them.
IMPORTANT RISK INFORMATION
- Do not give IBSRELA to children who are less than 6 years of age. It may harm them.
- You should not give IBSRELA to children 6 years to less than 18 years of age. It may harm them. IBSRELA can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
- Do not take IBSRELA if a doctor has told you that you have a bowel blockage (intestinal obstruction).
Before you take IBSRELA, tell your doctor about your medical conditions, including if you are:
- Pregnant or plan to become pregnant. It is not known if IBSRELA will harm your unborn baby.
- Breastfeeding or plan to breastfeed, although IBSRELA is not expected to pass into your breast milk and to harm your baby. Talk with your doctor about the best way to feed your baby if you take IBSRELA.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
Side Effects
Diarrhea is the most common side effect of IBSRELA, and it can sometimes be severe. Stop taking IBSRELA and call your doctor if you develop severe diarrhea.
Other common side effects of IBSRELA include swelling, or a feeling of fullness or pressure in your abdomen (distension), gas (flatulence), or dizziness.
These are not all the possible side effects of IBSRELA. Call your doctor for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to www.fda.gov/medwatch.
What is IBSRELA?
IBSRELA (tenapanor) is a prescription medicine used in adults to treat irritable bowel syndrome with constipation (IBS-C). It is not known if IBSRELA is safe and effective in children less than 18 years of age.
Please also see Medication Guide within the full Prescribing Information.
You are now leaving IBSRELA.com
This link will take you to a site maintained by a third party, who is solely responsible for its contents. Ardelyx, Inc., provides these links as a service to our website visitors. Ardelyx Inc., is not responsible for the content or Privacy Policy of any third-party websites. We encourage you to read the Privacy Policy of every website you visit.
IMPORTANT RISK INFORMATION
- Do not give IBSRELA to children who are less than 6 years of age. It may harm them.
- You should not give IBSRELA to children 6 years to less than 18 years of age. It may harm them. IBSRELA can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
- Do not take IBSRELA if a doctor has told you that you have a bowel blockage (intestinal obstruction).
Before you take IBSRELA, tell your doctor about your medical conditions, including if you are:
- Pregnant or plan to become pregnant. It is not known if IBSRELA will harm your unborn baby.
- Breastfeeding or plan to breastfeed, although IBSRELA is not expected to pass into your breast milk and to harm your baby. Talk with your doctor about the best way to feed your baby if you take IBSRELA.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
Side Effects
Diarrhea is the most common side effect of IBSRELA, and it can sometimes be severe. Stop taking IBSRELA and call your doctor if you develop severe diarrhea.
Other common side effects of IBSRELA include swelling, or a feeling of fullness or pressure in your abdomen (distension), gas (flatulence), or dizziness.
These are not all the possible side effects of IBSRELA. Call your doctor for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to www.fda.gov/medwatch.
What is IBSRELA?
IBSRELA (tenapanor) is a prescription medicine used in adults to treat irritable bowel syndrome with constipation (IBS-C). It is not known if IBSRELA is safe and effective in children less than 18 years of age.
Please also see Medication Guide within the full Prescribing Information.
